Literature DB >> 1082403

Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells.

R C Hard.   

Abstract

Host versus graft (HVG) syndrome may be induced in parental strain mice by perinatal inoculations of F1 hybrid spleen cells. The principal manifestations of the disease include thrombocytopaenia, intravascular fibrin deposits, intestinal haemorrhage, hepatic infarcts, lymphosplenomegaly and renal disease. Immune complexes have been shown to be the cause of the renal lesions, and have been implicated as the triggers for disseminated intravascular coagulation. In the present studies of RFM mice perinatally inoculated with (T6 x RFM)F1 spleen cells (RFM/(T6 x RFM)F1 mice), quantitative determinations of serum immunoglobulins (Ig) revealed marked elevations of IgG1, IgG2, IgA and IgM. Electrophoretic analyses revealed the polyclonal pattern which typically follows chronic antigenic stimulation. However, IgG1 levels which reached 29 to 72 times control values suggested disruption of homeostatic mechanisms which control circulating Ig levels. Because antibody responses to histocompatibility antigens were present only occasionally, and then in low titre, it seemed unlikely these antigens were the principal causes of hypergammaglobulinaemia and plasmacytosis. Morphological studies indicated that the elevated levels of Ig seen in end-stage HVG syndrome correlated well with marked plasmacytosis, the third morphological finding in a sequence that included the precocious development of germinal centres and subsequent depletion of thymic-dependent (T) lymphocytes. The fact that spleen cells from RFM/(T6 x RFM)F1 mice were severely impaired in their capacity to cause graft versus host disease in related (T6 x RFM)F1 and unrelated C3H mice provided strong evidence that the HVG reaction resulted in T-cell depletion, rather than specific immunoincompetence.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1082403      PMCID: PMC1538284     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  IMMUNOELECTROPHORETIC CHANGES IN MOUSE GAMMA-GLOBULIN AFTER INTRAPERITONEAL INJECTION OF BAYOL F.

Authors:  N TALAL; G HERMANN; P GRABAR
Journal:  J Immunol       Date:  1964-05       Impact factor: 5.422

2.  FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION.

Authors:  J L FAHEY; A G ROBINSON
Journal:  J Exp Med       Date:  1963-11-01       Impact factor: 14.307

3.  THE IMMUNOGLOBULINS OF MICE. 4. SERUM IMMUNOGLOBULIN CHANGES FOLLOWING BIRTH.

Authors:  J L FAHEY; W F BARTH
Journal:  Proc Soc Exp Biol Med       Date:  1965-03

4.  AN H-2 ANALYSIS OF STRAIN RFM/UN MICE.

Authors:  D M POPP; D B AMOS
Journal:  Transplantation       Date:  1965-07       Impact factor: 4.939

5.  Antibody production in inbred strains of mice.

Authors:  M A FINK; V A QUINN
Journal:  J Immunol       Date:  1953-01       Impact factor: 5.422

6.  Role of the thymus in neonatal life.

Authors:  D M PARROTT; J EAST
Journal:  Nature       Date:  1962-07-28       Impact factor: 49.962

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  Thymus-marrow cell combinations. Synergism in antibody production.

Authors:  H N Claman; E A Chaperon; R F Triplett
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

9.  7Sgamma-1 and 7Sgamma-2 antibody response in the mouse. I. Influence of strain, antigen and adjuvant.

Authors:  J E Coe
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

10.  HOMEOSTASIS OF ANTIBODY FORMATION IN THE ADULT RAT.

Authors:  D A ROWLEY; F W FITCH
Journal:  J Exp Med       Date:  1964-12-01       Impact factor: 14.307

View more
  8 in total

1.  Tumor induction in host-versus-graft disease. I. Clinical and pathologic features.

Authors:  E A Cornelius
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

2.  The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis.

Authors:  P Hughes; S Holt; N R Rowell; I D Allonby; K Janis; J K Dodd
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

Review 3.  Pathology, immunology and virology of the host versus graft syndrome.

Authors:  R C Hard; S S Cross
Journal:  Surv Immunol Res       Date:  1983

4.  Clinical and immunological associations in myasthenia gravis. 2. Cell-mediated immunity.

Authors:  H J Sagar; G A Davies-Jones; I D Allonby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

5.  Sequential changes in serum immunoglobulin levels in young RFM mice with host-versus-graft disease.

Authors:  R C Hard
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

6.  Expression of murine leukemia viruses in RFM mice with host versus graft disease after perinatal inoculation of (T6 X RFM)F1 lymphohemopoietic cells.

Authors:  S S Cross; G Brede; H S Tucker; M Maloney; J L Montour; R C Hard
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

7.  Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic sclerosis.

Authors:  J K Wright; P Hughes; N R Rowell; I B Sneddon
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

8.  Immunodeficiency in RFM/(T6xRFM)F1 mouse chimaeras with lethal host-versus-graft syndrome.

Authors:  R C Hard; J L Montour; B A Fuchs
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.